Chlamydia trachomatis: time for screening?
| Autor: | V. Lakiotis, D. Mauri, A. Spiliopoulou, D. Zavou, A. Vittoraki |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Sexually transmitted disease
Microbiology (medical) DNA Bacterial Male medicine.medical_specialty Cervicitis Chlamydia trachomatis Urine medicine.disease_cause genital infection Polymerase Chain Reaction Pelvic inflammatory disease medicine Humans Mass Screening Urethritis Mass screening Cervical cancer screening programme business.industry Obstetrics General Medicine sexually transmitted disease Tubal factor infertility Chlamydia Infections medicine.disease Europe Infectious Diseases Infertility Immunology Female business |
| Zdroj: | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 11(9) |
| ISSN: | 1198-743X |
| Popis: | Genital Chlamydia trachomatis infection is the leading cause of bacterial sexually transmitted disease in industrialised countries, particularly among young people. The consequences of chlamydial infection may involve urethritis, cervicitis, pelvic inflammatory disease, ectopic pregnancy, tubal factor infertility, epididymitis and prostatitis. In addition, chlamydial infection increases the risk of acquisition of human immunodeficiency virus and has been associated with cervical cancer. Although screening programmes exist in a number of countries, the continuously increasing prevalence of chlamydial infections demonstrates the necessity for health authorities to establish effective screening policies, and the importance of defining a comprehensive European screening policy is emerging. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|